This webinar will define the basic principles and importance of unwanted immunogenicity of biological drug candidates. Discussion will focus on potential causes of immunogenicity, impact on safety and efficacy of anti-drug antibody development. Risk factors and risk based approach in predicting, evaluating and mitigating of immunogenicity responses will be discussed. Current trends in immunogenicity assessment will be reviewed.
Boris Gorovits PhD,
PERI Course Code: WH4
Full Archive Available for Purchase: $275 for 30-days unlimited access.
Call PERI at 703-276-0178 for details.